News

The decision was made following receipt of the results of the Herpevac trial for women, a Phase III trial evaluating efficacy of Simplirix, which was conducted collaboratively with

As per the agreements, Covance expects to provide drug development services to Sanofi-aventis, with estimated payments ranging from about $1.2bn to $2.2bn. However, Sanofi-aventis will sell its Porcheville,

Study results showed that Budesonide MMX 9mg taken once daily met the primary endpoint of superiority to placebo in achieving clinical remission as measured by the ulcerative colitis

Most recently, Parsey worked at Genentech, a member of the Roche Group as the senior group medical director in Genentech Research and Early Development, overseeing early clinical development

Prior to joining Altheos, Wirostko worked with Pfizer as the senior medical director and the glaucoma medical team lead and was responsible for pipeline strategy in glaucoma, overseeing

Qualitest said that after a thorough evaluation of multiple quality management solutions, it has selected a phased implementation of TrackWise software for its ability to deliver a flexible,

Microplasmin, ThromboGenics’ lead drug candidate, is a truncated form of the natural human protein plasmin. ThromboGenics has recently concluded two Phase III trials of Microplasmin, assessing the patients

Most recently, Bacopoulos worked as president and CEO of Aton Pharma. Prior to Aton Pharma, Bacopoulos served as the president and head of R&D at OSI Pharmaceuticals, where

DX-88 has received approval from the US Food and Drug Administration (FDA) and is marketed as Kalbitor (ecallantide) for the treatment of acute attacks of HAE in patients